Who gets credit when AI designs a drug?
Insilico Medicine announced that a molecule for pulmonary fibrosis was “discovered by” its generative AI platform after the company used models to propose the candidate. The report situates Insilico among firms using AI to generate novel drug ideas that humans might not think of.